A

Actinium Pharmaceuticals Inc
AMEX:ATNM

Watchlist Manager
Actinium Pharmaceuticals Inc
AMEX:ATNM
Watchlist
Price: 1.58 USD -1.25%
Market Cap: 49.3m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ATNM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATNM Intrinsic Value
Not Available
Base Case Scenario
Compare ATNM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATNM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Actinium Pharmaceuticals Inc

Current Assets 61m
Cash & Short-Term Investments 59.9m
Other Current Assets 1.1m
Non-Current Assets 2m
PP&E 1.7m
Other Non-Current Assets 329k
Current Liabilities 8.3m
Accounts Payable 7.7m
Accrued Liabilities 589k
Other Current Liabilities 11k
Non-Current Liabilities 35.7m
Long-Term Debt 5k
Other Non-Current Liabilities 35.7m
Efficiency

Free Cash Flow Analysis
Actinium Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Actinium Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-44.2m USD
Operating Income
-44.2m USD
Other Expenses
3.2m USD
Net Income
-41m USD
Fundamental Scores

ATNM Profitability Score
Profitability Due Diligence

Actinium Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
hidden
Profitability
Score

Actinium Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ATNM Solvency Score
Solvency Due Diligence

Actinium Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Actinium Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATNM Price Targets Summary
Actinium Pharmaceuticals Inc

Wall Street analysts forecast ATNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATNM is 5.1 USD with a low forecast of 2.02 USD and a high forecast of 9.45 USD.

Lowest
Price Target
2.02 USD
28% Upside
Average
Price Target
5.1 USD
223% Upside
Highest
Price Target
9.45 USD
498% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Actinium Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ATNM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ATNM Insider Trading
Buy and sell transactions by insiders